Nippon Shinyaku Co Ltd ADR (NPPNY)
Nippon Shinyaku Co., Ltd. is the underlying issuer for this OTC-listed ADR, a depositary receipt representing common stock of the Japanese company on OTC Markets under the symbol NPPN.Y. The company develops, manufactures, and sells pharmaceuticals and food products in Japan and overseas. Its operations are organized into Pharmaceuticals and Functional Food Business segments. In pharmaceuticals, it markets medicines used in areas such as urology, hematology, gynecology, and treatments for rare and intractable diseases. Its food-related activities include health food ingredients, preservatives, protein preparations, and supplements. Nippon Shinyaku also participates in research collaborations involving ATSN-10 for GUCY2D-mutant Leber congenital amaurosis and RGX-121 for mucopolysaccharidosis. Founded in 1911 and headquartered in Kyoto, Japan, the company has a long operating history in healthcare and functional food products.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-NPPN.Y
|
$9.18
|
52.9% Upside
|
Bargain
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
August 7, 2026
|
9.2x
|
0.9x
|
1.6x
|
1.661 B
|
810.3 M
|
0.9%
|
93.1%
|
15.4
|
28.1%
|
81.6%
|
